Evercore ISI Raises Oracle (NYSE:ORCL) Price Target to $175.00

Oracle (NYSE:ORCLFree Report) had its target price raised by Evercore ISI from $160.00 to $175.00 in a research note published on Tuesday morning, Benzinga reports. The firm currently has an outperform rating on the enterprise software provider’s stock.

ORCL has been the topic of several other reports. Guggenheim reissued a buy rating and issued a $175.00 target price on shares of Oracle in a research report on Tuesday, June 25th. Deutsche Bank Aktiengesellschaft raised their price objective on Oracle from $150.00 to $165.00 and gave the stock a buy rating in a research note on Monday, June 17th. UBS Group upped their target price on Oracle from $160.00 to $175.00 and gave the company a buy rating in a research report on Tuesday. StockNews.com lowered shares of Oracle from a buy rating to a hold rating in a research report on Thursday, June 6th. Finally, Piper Sandler upped their price objective on shares of Oracle from $150.00 to $175.00 and gave the company an overweight rating in a report on Tuesday. Eleven research analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of Moderate Buy and a consensus price target of $158.68.

Read Our Latest Analysis on ORCL

Oracle Trading Up 2.7 %

Shares of NYSE:ORCL opened at $161.36 on Tuesday. The company has a debt-to-equity ratio of 8.25, a current ratio of 0.71 and a quick ratio of 0.72. The firm has a market capitalization of $444.69 billion, a P/E ratio of 43.49, a P/E/G ratio of 2.56 and a beta of 1.01. The business’s 50-day moving average is $139.50 and its 200 day moving average is $129.55. Oracle has a 1 year low of $99.26 and a 1 year high of $162.34.

Oracle (NYSE:ORCLGet Free Report) last announced its quarterly earnings data on Monday, September 9th. The enterprise software provider reported $1.39 EPS for the quarter, beating the consensus estimate of $1.33 by $0.06. The firm had revenue of $13.31 billion during the quarter, compared to analyst estimates of $13.23 billion. Oracle had a net margin of 19.76% and a return on equity of 223.01%. Oracle’s revenue was up 6.9% on a year-over-year basis. During the same period last year, the firm posted $0.95 EPS. On average, research analysts predict that Oracle will post 5.02 earnings per share for the current fiscal year.

Oracle Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 24th. Shareholders of record on Thursday, October 10th will be issued a $0.40 dividend. The ex-dividend date is Thursday, October 10th. This represents a $1.60 dividend on an annualized basis and a yield of 0.99%. Oracle’s payout ratio is currently 43.13%.

Insiders Place Their Bets

In other news, Director Jeffrey Berg sold 22,500 shares of the firm’s stock in a transaction dated Thursday, June 20th. The shares were sold at an average price of $143.12, for a total value of $3,220,200.00. Following the transaction, the director now directly owns 210,712 shares of the company’s stock, valued at $30,157,101.44. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, Director Jeffrey Berg sold 22,500 shares of the stock in a transaction that occurred on Thursday, June 20th. The stock was sold at an average price of $143.12, for a total value of $3,220,200.00. Following the completion of the sale, the director now owns 210,712 shares of the company’s stock, valued at $30,157,101.44. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Edward Screven sold 235,918 shares of the business’s stock in a transaction on Thursday, June 20th. The stock was sold at an average price of $144.30, for a total value of $34,042,967.40. Following the transaction, the insider now directly owns 2,626,764 shares in the company, valued at approximately $379,042,045.20. The disclosure for this sale can be found here. Insiders have sold a total of 1,862,500 shares of company stock valued at $266,776,624 in the last 90 days. 42.80% of the stock is owned by insiders.

Hedge Funds Weigh In On Oracle

Institutional investors have recently bought and sold shares of the company. Werlinich Asset Management LLC raised its position in shares of Oracle by 3.1% during the 2nd quarter. Werlinich Asset Management LLC now owns 2,325 shares of the enterprise software provider’s stock valued at $326,000 after buying an additional 70 shares during the period. RFP Financial Group LLC increased its stake in Oracle by 2.7% during the second quarter. RFP Financial Group LLC now owns 2,869 shares of the enterprise software provider’s stock worth $405,000 after acquiring an additional 75 shares during the last quarter. Invst LLC raised its position in Oracle by 2.4% in the second quarter. Invst LLC now owns 3,372 shares of the enterprise software provider’s stock valued at $482,000 after purchasing an additional 79 shares during the period. ERn Financial LLC lifted its stake in shares of Oracle by 0.6% in the 2nd quarter. ERn Financial LLC now owns 12,911 shares of the enterprise software provider’s stock valued at $1,823,000 after purchasing an additional 80 shares during the last quarter. Finally, Key Financial Inc grew its holdings in shares of Oracle by 1.2% during the 2nd quarter. Key Financial Inc now owns 6,600 shares of the enterprise software provider’s stock worth $932,000 after purchasing an additional 80 shares during the period. 42.44% of the stock is owned by hedge funds and other institutional investors.

Oracle Company Profile

(Get Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Read More

Analyst Recommendations for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.